mRNA |
BMS-536924 |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.1 |
mRNA |
SR8278 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.1 |
mRNA |
BRD-A94377914 |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.1 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.1 |
mRNA |
NU-7441 |
GDSC1000 |
pan-cancer |
AAC |
0.052 |
0.1 |
mRNA |
BMS-536924 |
GDSC1000 |
pan-cancer |
AAC |
0.047 |
0.1 |
mRNA |
PHA-665752 |
GDSC1000 |
pan-cancer |
AAC |
-0.075 |
0.1 |
mRNA |
Imatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.1 |
mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
-0.078 |
0.1 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.1 |